Precursors of CD3+CD4+CD8+ cells in the human thymus are defined by expression of CD34. Delineation of early events in human thymic development by unknown
Precursors of CD3 +  CD4 +  CD8 +  Cells in the Human 
Thymus  Are Defined  by Expression  of CD34. 
Delineation  of Early Events in Human  Thymic 
Development 
By Anne Galy, Sunita Verma, Alicia B~ircena, and Hergen Spits 
From DNAX Research Institute, Department of Human Immunology, Palo Alto, 
California 94304 
Summary 
Studies of the most immature T  cell progenitors in the human thymus have been hampered 
by the lack of markers and assays that define these cells. In this report we used a novel human 
fetal thymic organ culture system to determine the potential of T cell precursors isolated from 
human postnatal thymus, to differentiate into CD3 + thymocytes, and to investigate early stages 
of human T cell development. It was found that thymocytes that lack the markers CD3, CD4, 
and CD8 (triple negative [TN]) can differentiate in an allogeneic organotypic thymic culture. 
The capacity of TN thymocytes to differentiate was exclusively confined to the CD34 + popu- 
lation.  CD34-  TN thymocytes failed to differentiate in this system. In contrast,  cloned lines 
of CD3-  thymocytes could only be established from CD34-  TN thymocytes. Five subsets of 
CD3-  thymocytes  were  found  with  the  following  phenotype:  CD1-TN,  CDI+TN, 
CD1 +  CD4 +  CD8-, CD1 +  CD4 +  CD8c~  +  fl-, and CD1 +  CD4 +  CD8cxfl  +. These subpopulations 
expressed decreasing levels of CD34. The CD1- CD3- population expressed the highest levels 
of CD34 supporting the notion that this population is the most immature T cell precursor in 
the thymus, whereas the CDI+CD4 +  CD8c~+fl + which did not express CD34 seems to be the 
most mature of these CD3-  populations.  This notion is supported by the observations that 
CD34 + cells isolated from fetal liver, which differentiated into T cells in a FTOC, developed 
into CD3 + cells via CD1-  and CD4+CD8 -  intermediates.  Based on these data, we present 
a model of early stages in human intrathymic development. 
I 
t is generally accepted that the most early thymic T cell 
progenitors are cortical  thymocytes that do not express 
the TCR-CD3 complex or the coreceptors CD8 and CD4. 
In the cortex, these cells develop into thymocytes  expressing 
CD4 and CD8 and low levels of CD3. A small proportion 
of these double positive (DP) cells are rescued from programed 
cell death by positive selection, presumably involving TCR/ 
MHC and appropriate  CD4-CD8/MHC interactions,  and 
develop further into single positive (SP) thymocytes (1, 2). 
Studies of intrathymic developmental pathways in mice have 
been aided by the availability of an in vitro fetal organ cul- 
ture system (3, 4) and intrathymic injection into host mice 
(5-7). These assays have  been particularly useful for delinea- 
tion of early events in thymic development and have allowed 
characterization of the most immature murine T cell precur- 
sors. By contrast, the study of human thymic T cell progen- 
itors has been hampered by the lack of markers as well as 
differentiation assays that unequivocally define these cells, al- 
though there is consensus that the most immature human 
thymocytes  lack CD3, CD4, and CD8 (8-11). Several  groups 
have reported that human triple negative (TN)  t cells respond 
to IL-2 and differentiate in vitro to TCK-cx/fl  + or to TCK- 
3'//~ + cells in simple culture systems either in the presence 
or absence of thymic stromal cells (12-15). In contrast, we 
found that highly purified TN thymocytes do not respond 
to IL-2 or IL-4, but strong proliferation was observed in the 
presence of IL-7. Short-term culture of TN thymocytes in 
IL-7 induced CD4 and CDSa on these cells, but the cells 
did not acquire the CD3-TCK complex upon culture in IL-7 
(16). We reasoned that differences in the methods to purify 
TN thymocytes and the criteria to assess purity of the TN 
cell samples could be responsible for the differences in results 
reported by different groups (16). To solve this question  it 
was important to find a marker that would positively iden- 
tify immature thymocytes and to develop an assay to mea- 
1 Abbreviations  used in tkis ~t,er: DP, double positive; FTOC, fetal thymic 
organ culture;  lin,  lineage; SP, single positive; TN, triple negative. 
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cells. A potential marker for intrathymic T cell progenitors 
is CD34. CD34 is a 120-kD cell surface antigen that is ex- 
pressed on pluripotent hematopoietic stem (17-19) cells and 
on precursors  that are committed to several hematopoietic 
lineages, including the B (20), myeloid, and erythroid lineages 
(17, 18). CD34 is therefore not a lineage-specific marker, but 
can be considered as a stage-specific marker identifying im- 
mature hematopoietic cells. Although a number of groups 
have reported expression  of CD34 in immature thymocytes, 
the proportion of thymic TN cells that express CD34 is con- 
troversial.  Kurtzberg et al. (21) reported that 26% of these 
cells express CD34, while Poggi et al.  (22) did not detect 
CD34 on CD1-TN thymocytes, considered to be the most 
early T  cell precursors  in the thymus (22).  In contrast, we 
have found that in most samples  of thymocytes that were 
rigorously depleted of CD3,CD4, and CD8 positive cells by 
a combination of magnetic and fluorescent cell sorting, >90% 
of the cells expressed CD34 (16). Similar findings were reported 
by Terstappen  et al. (23).  The finding that CD34 + thymo- 
cytes coexpress CD2, CDS, and CD7, suggest that these cells 
are T cell precursors (16, 23), but direct proof of this notion 
is lacking. Moreover,  the possibility that CD34-  TN thy- 
mocytes also contain T cell precursors could not be dismissed. 
It has been reported that CD34 cells from fetal liver  or 
fetal bone marrow can develop  into T  cells when injected 
into thymic fragments that are subsequently transplanted in 
SCID mice (24). Jenkinson and co-workers (3, 4) have shown 
that in the mouse system early thymic progenitors can de- 
velop in fetal thymic lobules in vitro, indicating that an in 
vivo environment is not an absolute requirement for T  cell 
development. Based  on this information, we developed  a 
human in vitro fetal thymic organ culture (FTOC) system 
to investigate the T cell differentiating potential of CD34 + 
and CD34-  TN thymocytes. To obtain information about 
the early stages of human T cell development, we examined 
the kinetics of development of CD3 + cells from CD34 + 
fetal liver  cells. 
Materials and Methods 
Preparation of Thymocyte Suspensions and Thymocyte Subpopula- 
tions.  Thyrnic tissue was obtained from children of 3 mo to 10 
yr of age undergoing median sternotomy and corrective cardiovas- 
cular surgery. Suspensions  were made by mincing tissue and pressing 
through a stainless steel mesh. Large aggregates were removed and 
the cells were washed once before separating subpopulations. For 
preparation of CD34 § TN cells, thymocytes were incubated with 
the antibodies IkPA-T4 (CD4) and RPA-T8 (CD8) (kind gifts of 
Dr. G. Aversa, DNAX Research Institute) and then incubated  with 
magnetic beads coated with sheep anti-mouse antibody (Dynal, 
Oslo, Norway). After a first round of depletion with a magnet, 
the cells were incubated with PE-labeled antibodies against CD19 
(Leul2), CD14 (LeuM3), CD33 (LeuM9), CD56 (Leul9) (all Leu 
antibodies obtained from Becton Dickinson & Co., San Jose, CA), 
and with an antibody against glycophorin (10F7MN; American 
Type Culture Collection (ATCC), Rockville, MD) followed  by an- 
other round of magnetic sorting to remove B, NK, myeloid, and 
erythroid cells. The remaining  cells were then incubated  with FITC- 
labeled anti-CD34 (HPCA-2; Becton Dickinson & Co.) and with 
PE-labeled CD3 (Leu4), CD4 (Leu3a), and CD8 (Leu2a). Leu2a 
and Leu3a are directed against epitopes different from RPA-T4 and 
RPA-T8 which  were used  for  the  magnetic  bead depletion. 
CD34 §  CD3-CD4-CD8-CD14-CD19-CD33-CD56-  cells 
were then sorted with the FACStar Plus  |  (Becton Dickinson & 
Co.). Only cells that were more than 99% pure upon reanalysis, 
were used for subsequent experiments. 
To prepare CD8~-  samples, total thymocytes were incubated 
with anti-CDSB antibodies (2STS-5H7; a kind gift of  Dr. E. Rein- 
hertz, Dana Farber Cancer Institute, Boston, MA) for 30 min at 
4~  and then with magnetic beads coated with goat anti-mouse 
antibody. PE-labeled CD3 (Leu4, Becton Dickinson & Co.) was 
added to the remaining cells followed by another round of mag- 
netic bead depletion. PE-Leu4 was used at this point to check for 
possible modulation of CD3 during the separation, since internal- 
ized anti-CD3-PE would still be detectable because of the bright- 
ness of the fluorochrome.  To remove  resident thymic B cells, mono- 
cytes, myeloid progenitors, NK cells, and erythrocytes, antibodies 
against CD19 (Leu12), CD14 (LeuM3), CD33 (LeuM9), CD56 
(Leu19), and glycophorin (10FTMN) were also added at this stage. 
Remaining CD3 +  , CD83 +, CD14 §  CD19 +  , CD33 +, CD56 § , 
and  glycophorin +  cells were  stained  with  PE-labeled  goat 
anti-mouse IgG or IgG2a (Caltag Laboratories,  San Francisco,  CA~, 
and PE-stained  cells were removed  by sorting on the FACStar  Plus  . 
For three-color analysis of the CD3- CD83- thymocytes,  we used 
Leu2(CD8)-FITC, HPCA-2(CD34)-PE, and Leu3(CD4) labeled 
with  peridinin chlorophyll protein  (PerCP; Becton Dickinson 
& Co.). 
Isolation of CD34 § Fetal Liver Progenitors.  Fetal  liver tissue (18 
wk of gestational age and HLA-A2  §  was homogenized through 
a wire mesh under a stream of RPMI 1640 containing 10% FCS. 
The cellular suspension was centrifuged over Histopaque (Sigma 
Chemical Co., St. Louis, MO). The remaining RBC were removed 
by negative selection using magnetic beads. Cells were incubated 
with anti-glycophorin antibody (10F7 MN; obtained from the 
ATCC) for 30 rain at 4~  The cells were washed twice with PBS 
supplemented with 5 mg/ml BSA (Sigma Chemical Co.) and 0.2 
mg/ml NAN3, and then incubated with with magnetic beads 
coated with purified sheep anti-mouse IgG (Dynabeads, Dynal). 
After removal of cells bound to beads with the magnet (Dynal), 
these cells were incubated for 30 min at 4~  with saturating 
amounts of the following mAbs: Leu4-FITC (CD3), Leu3a-FITC 
(CD4),  Leu2a-FITC (CD8),  Leu16-FITC (CD20), Leu12-FITC 
(CD19), and LeuM3-FITC  (CD14) (all obtained from Becton Dick- 
inson & Co.); IOM13-FITC  (CDD; AMAC, Inc., Westbrook, ME), 
and L185-FITC (CD56; kindly provided  by Dr. J. Phillips, DNAX 
Research Institute). After washing, cells were incubated with Dy- 
nabeads, coated with sheep anti-mouse IgG, and the lineage (lin)  + 
cells were removed. The depleted cell population, which still con- 
tained some FITC-labeled  cells, was stained  with HPCA-2-PE mAb 
(CD34) and the  CD34 + lin-  and the  CD34-  lin-  cells were 
sorted with a FACStar Plus  |  Both cell populations were >99% 
pure upon reanalysis. 
FTOC.  Human fetal tissue, from donors of 17-20 wk of gesta- 
tional age, was obtained from elective therapeutic abortions (Ad- 
vanced Bioscience Research, Alameda, CA). Thymic fragments, 
containing 3-8 lobules were placed on nucleopore falters (0.8/~m; 
Costar  Corp.,  Cambridge,  MA)  over gelfoam rafts  (Upjohn, 
Kalamazoo, MI) and cultured for 7 d on 6-well  plates (Becton  Dick- 
inson & Co.) at 25~  5%  CO2 in Yssel's medium (25) sup- 
plemented  with 1% human serum. To avoid  expansion  of  remaining 
endogenous thymocytes, the fragments were irradiated at 500 rad 
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purified CD34 + TN thymocytes  with 1-mm micropipettes (World 
Precision Instruments, Inc., Sarasota, FL) in 0.5/A of  Yssel's medium 
using a Nikon injector (Nikon, Narishige, Japan). The injected 
thymic fragments were returned to the filters on the rafts and cul- 
tured in Yssel's medium at 37~  in a humidified 5% CO2 at- 
mosphere. At the end of the incubation periods, thymic pieces  were 
homogenized by gentle pipetting in PBS containing 5 mg/ml BSA 
and 0.2 mg/ml NaN3 and subjected to phenotypic analysis. 
Three-color phenotypic analysis of 2-3  x  10  ~ cells was per- 
formed after incubating the cells  with PBS supplemented with 2% 
FCS and 2% normal mouse serum for 10 min, followed  by 30 min 
staining with anti-HLA-A2-FITC  mAb (CRll-351; kindly provided 
by Dr. S. Ferrone, New York Medical College, Valhalla, NY) or 
with HLA-A3-FITC (GAP-A3; ATCC) and CDI-PE (T6-RD; 
Coulter Corp., Hialeah, FL), and with biotinylated or PE-labeled 
Leu4 (CD3), Leu3a (CD4), and Leu2a (CDS). After two washes 
in PBS containing 5 mg/ml BSA and 0.2 mg/ml NAN3, the cells 
were incubated with Streptavidin TriColor (Caltag Laboratories), 
washed, and subjected  to cytofluorometric  analysis  with a FACScan  | 
(Becton Dickinson & Co.). The results are expressed as the per- 
centage of cells expressing a given antigen within the HLA-A2 or 
HLA-A3 positive population. The number of cells per piece were 
calculated by multiplying the total number of cells recovered per 
fragment of thymus by the percentage of HLA-A2 or A3 § cells 
in the population. 
Cloning of Immature Thymocytes.  TN thymocyte subsets were 
cloned as has been described previously (26). Briefly, dilutions of 
CD34 + and CD34- cells were deposited in one well of a 96-well 
plate (Costar Corp.) in 100 gl Yssel's medium containing a feeder 
cell mixture composed of 10  s irradiated (4,000 tad) PBMC, 104 
irradiated (5,000 rad)  JY (EBV-transforraed  B cells)  cells, and 5 ng/ml 
purified PHA (Wellcome, Beckenham, Kent, UK).  7 d later, 20 
U/ml IL-2 (a kind gift of  Dr. G. Zurawsky,  DNAX Research Insti- 
tute) was added, and 14 d after the onset of the cloning growing 
cultures were transferred into 24-well plates and restimulated with 
feeders. 10 d later, individual clones were analyzed for expression 
of CD3, CD4, CDS, and CD56. 
Results 
Purified CD34 + TN Thymocytes Develop into DP Thymo- 
cytes in a FTOC.  HLA-A3 § thymocytes were depleted of 
CD4 §  CD8 +,  B,  NK,  myeloid,  and  erythroid cells  by 
magnetic bead depletion as indicated in Materials and Methods. 
PE-labeled  antibodies against CD19  and CD56 were used 
during the magnetic bead depletion. The remaining ceils were 
labeled with anti-CD3-PE, with PE-labeled antibodies against 
CD4 and CD8 (directed against different epitopes as those 
used for the magnetic bead depletion) and CD34-FITC. Elec- 
tronic gates were placed  on the FITC+PE -  (CD34 +) and 
FITC-PE-  (CD34-) cells as indicated in Fig.  1 followed by 
sorting. Different numbers of CD34 + cells (3  x  102, 3  x 
103, and 3  x  104), which were 99.3%  pure and 3  x  104 
CD34-  cells  (99.4%  pure)  were injected into HLA-A3- 
fetal thymic fragments, that were precultured for 7 d at room 
temperature and irradiated to remove endogenous thymocytes. 
The injected fetal thymic fragments were cultured at 37~ 
at an air-liquid interphase for 21 d. Fig. I  shows that only 
the CD34 + cells developed into HLA-A3 + CD3 + cells in 
this FTOC. The very few cells recovered from fragments in- 
CD34-FITC 
CD34- cells  (Gate 1 )  CD34+ cells (Gate 2 ) 
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Figure 1.  CD34  + thymocytes  differentiate  into CD3 + ceils, whereas 
CD34- cells  do not grow or differentiate  into CD3 + T cells in FTOC. 
After depletion of CD3, CD4, CD8, CD19, and CD56 positive cells, 
CD34 + and CD34- cells were sorted after setting of the gates as indi- 
cated in the figure,  and 3 x 103 CD34 + and 3 x  104 CD34- cells  were 
injected  into thymic  fragments  as indicated  in Materials  and Methods.  The 
thymic fragments were cultured for 21 d as indicated in Materials and 
Methods. The fragments were homogenized, the recovered cells were 
counted and subjected  to three-color  analysis  as indicated  in Materials  and 
Methods. The number of cells recovered  after  injection  of 3 x 103 CD34  + 
cells was 1.3  x  104 cells per fragment and of 3 x  104 CD34- TN cells 
was 0.15  ￿  104 cells per fragment. 
jected with CD34-  thymocytes were HLA-A3- indicating 
their recipient origin. Fig. 2 demonstrates that 300 cells injected 
per fragment resulted in the appearance of CD4 +  CD3 + cells 
of donor  origin.  The  great  majority of the  HLA-A3 § 
thymocytes that developed  in the thymic organs expressed 
CD1 and were DP (Fig.  3),  whereas ~1%  of the cells are 
CD3highCDI-, indicating that some mature thymocytes of 
donor origin were present in these organs. A minor popula- 
tion of HLA-A3-  (recipient derived)  cells was also present 
in suspensions  of fragments injected with different doses of 
purified  HLA-A3+CD34 §  thymocytes  (Fig.  2).  Fig.  3 
shows that the majority of the HLA-A3- thymocytes lacked 
CD1 and CDS. In addition, almost all these HLA-A3- cells 
expressed  high levels of CD3 and CD4 (Fig.  4).  Taken to- 
gether, these data indicate that the majority of residual recip- 
ient thymocytes that are still present in the thymic fragments 
after  21  d  of culture  are  mature  CD3+CD4 +  cells.  Al- 
though not shown,  short-term incubation (up to 6 d) of 
CD34 + thymocytes in the presence  of IL-7 alone or with 
thymic epithelial cells (TEC), established as described previ- 
ously (27, 28),  and IL-7 did not result in the generation of 
either TCR-'yI~ or TCR-c~/3 cells. The frequency of con- 
taminating more  mature  T  cells  present  in  the  purified 
CD34 +  cells  used  to  inject  the  thymic  fragments  was 
checked by limiting dilution under conditions that allow high 
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Figure  2.  Development of varied numbers of HLA-A3 + CD34 § TN 
thymocytes  in HLA-A3-  fetal thymus organs.  3  x  10  2, 3  x  10  3,  and 
3  ￿  104 CD34 § ceils were injected into individual fetal thymic fragments 
and cultured for 21 d  as indicated in Materials and Methods.  The frag- 
ments were homogenized and the recovered cells were counted and sub- 
jected to three-color analysis as indicated in Materials and Methods. The 
recoveries of donor-derived (HLA-A3 +) cells per fragment were: after in- 
jection with 3  x  104 cells,  2.6  x  104 cells were recovered per fragment, 
after injection with 3  x  10  3 cells,  1.3  x  104 cells, and after injection with 
3  x  10 2 cells, 0.4  x  104 cells. 
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Figure  3.  Expression of CD1,  CD3,  CD4,  and CD8 on thymocytes 
recovered from F3"OC. Cells recovered from HLA-A3-  thymic fragments 
injected with 3  x  104 HLA-A3 +  cells per fragment were subjected to 
three-color analysis using labeled antibodies as indicated in Materials and 
Methods  and analyzed on a FACScan  | 
we analyzed  CD34  expression  on  these cells.  In pilot  ex- 
periments,  it  was  found  that  CD34  is  not  expressed  on 
CD8fl+CD3 + thymocytes as assessed with double staining 
using PE-labded anti-CD34 and FITC-labded anti-CD3 and 
cloning  efficiencies  of mature  T  cells.  The  frequency  of 
TCR/CD3 + cells that were donogenic under those condi- 
tions was <1:103 . 
Thymocyte SubFopulations  that Express CD34.  Previously 
we have shown that CD1  subdivides TN  thymocytes into 
two subsets (16).  The proportion of CD1 + vs CD1-  TN 
thymocytes varied from donor to donor, but the number of 
CD1-  TN cells exceeded that of CD34-  cells.  Therefore it 
was  expected  that  part  of the  CD1-  cells  would  express 
CD34. Fig. 5, which shows a double staining of TN thymo- 
cytes with anti-CD1-PE and anti-CD34-FITC, demonstrates 
that essentially all CD1 + TN cells express CD34. A propor- 
tion  of  CD1-  cells  expressed  CD34,  and  expression  of 
CD34  on  the  CD1-CD34 +  cells  was  higher  than  on 
CDl+CD34 +  thymocytes  (Fig.  5).  These results strongly 
suggest that CD1-CD34 + cells are the most immature cells 
followed by CD1 + CD34 + TN  thymocytes.  Previously we 
have demonstrated the existence of CD3- CD4 § CD8-  and 
of CD3- CD4 + CD8o~ +  fl-  populations  and provided  evi- 
dence that these subsets were the progeny ofTN thymocytes 
(16). To confirm the immature status of these subpopulations, 
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Figure  4.  Expression of CD3 and CD4 on donor-derived HLA-A3 * 
and recipient HLA-A3-  cells recovered from a  FTOC.  HLA-A3-  and 
HLA-A3 + cells from the same sample as shown in Fig. 2, were analyzed 
for CD3  and CD4 expression. 
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Figure 5.  Expression  of CD1 and CD34 on TN thymocytes.  Thymo- 
cytes were depleted of CD3, CD4, and CD8 positive  cells  by a combina- 
tion of magnetic  bead depletion  and sorting as indicated  in Materials and 
Methods and analyzed  for expression of CD1 and CD34. CD34 was ex- 
pressed on 75% of the cells in this sample. The nature of the CD34- 
cells in this sample was not investigated  further. 
CD8fl mAbs (results not shown). Therefore we restricted 
our analysis of CD34 expression to thymocytes that were 
depleted of CD3+CD83 + cells.  A  three-color analysis  of 
thymocytes that were depleted of CD3 and CD83 positive 
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Figure 6.  Expression  of CD34, CD4, and CD8cr on CD3-CD8~- 
thymocytes.  Thymocytes  were depleted  of CD3 + and CD8B  + cells as in- 
dicated in Materials and Methods. The population  was 99.5% pure (PE 
negative) by reanalysis. 
cells was carried out using anti-CD4-1abeled PerCP,  anti- 
CD8ot-FITC, and anti-CD34-PE. Anti-CD34-PE was used 
in this experiment rather than anti-CD34-FITC, since the 
former is 5-10-fold more sensitive than the latter and would 
allow detection of  low levels of CD34 expression. Fig. 6 shows 
the dot plot  of CD4  and CD8c~.  As expected from our 
previous  data,  three  populations  can  be  distinguished 
CD4-CD8c~-,  CD4+CD8ot -,  and  CD4+CD8ot +  cells. 
Analysis of each of these populations for CD34 expression, 
dearly demonstrates that CD4-8or-  expresses the highest 
levels of this antigen followed by CD4+8ot -  and then by 
CD4+8ot + cells. Note that CD3-CD4+CD8 -  cells are all 
CD34 +, whereas TN cells contain a few CD34-  cells. As 
shown above,  these TN CD34-  cells do not contain cells 
that  have  the  capacity to  develop  into  CD3 +  cells  in  a 
FTOC. Based on the analogy with findings indicating that 
expression of CD34 in the myeloid/erythroid  lineages decreases 
upon progressing maturation, our findings strongly suggest 
that CD34+CD1 -  TN thymocytes are the most immature 
followed by the CD34+CD1 +,  CD34+CD4+CD8 -,  and 
the CD34 • CD4 +  CD8ot § thymocytes. 
Earl  r  Kinetics of Development of CD34 + Fetal Liver Cells 
into  T  Cells in a FTOC.  To find further evidence  for the 
progeny-product relationship of the various immature thymo- 
cyte subsets as suggested by the level of expression of CD34, 
we investigated the kinetics ofT cell development in FTOC. 
It was reasoned that the early events could best be studied 
by following T  cell development of a source  of prethymic 
progenitor cells in a FTOC. In early embryogenesis, pluripo- 
tent hematopoietic stem cells are present in fetal liver. Since 
it has been shown that CD34 + fetal liver cells can develop 
into T cells (24), we used CD34 + fetal liver cells as a source 
of prethymic T  cell progenitors.  Fetal liver cells were first 
depleted of erythrocytes, T, B, NK, and mature myeloid cells, 
labeled with anti-CD34-PE and sorted with a FACStar Plus  | 
Fig. 7 shows that the sorted, lineage-negative, CD34 + cells 
lack the T  cell markers CD3, CD4,  and CD8, the mono- 
cyte/myeloid markers CD13 and CD14, the B cell markers 
CD19 and CD20, and the NK cell marker CD56. These cells 
expressed  HLA-A2  and  were  injected  into  HLA-A2- 
thymic fragments. At various intervals, thymic fragments were 
homogenized and the resulting cell suspensions  were ana- 
lyzed on a FACScan  |  for forward and side scatter parameters. 
An electronic gate was placed on cells with a small lymphoid 
size and expression  of CD1, CD3, CD4, and CD8 was ana- 
lyzed. The total number of HLA-A2 + small lymphoid cells 
recovered  from the thymic fragments was 3  x  104 on day 
10, which decreased to 1.6  x  104 on day 14 and increased 
again via 2.1  x  104 on day 17 to 7  x  104 cells per fragment 
on day 20. Fig. 8 shows that on day 10 few of these HLA- 
A2 + small lymphoid cells expressed  CD3, CD4, or CDS. 
By day 14,  80%  of these HLA-A2 + small cells expressed 
CD4,  28%  expressed  CD8,  and  2%  of these cells  were 
CD3 +.  The  number  of small,  HLA-A2 +  cells  that  ex- 
pressed both CD4 and CD8 cells increased with further in- 
cubation and by day 20, most of the cells coexpressed CD4 
and CD8 (Fig. 8). The percentage CD3 + ceils in the HLA- 
395  Galy et al. Figure  7.  Phenotype of CD34 + lineage- fetal liver cells. Glycophorin- 
negative fetal liver cells from a donor of 19 wk gestational  age, were ob- 
tained as described in Materials and Methods.  The cells were 99.5% pure 
upon reanalysis. Samples of sorted CD34 + lineage negative cells were in- 
cubated with FITC-labeled antibodies for 30 min at 4~  washed and ana- 
lyzed on the FACScan  |  The CD34 expression is shown in the box. Since 
the sorted cells were already labeled with anti-CD34-PE,  we used as nega- 
tive control the cells obtained  after depletion with magnetic beads but 
before CD34 sorting,  labeled with control IgGI-PE. 
DAY10 
DAY14 
DAY 17 
DAY 20 
HLA-A2-FITC  HLA-A2 FITC 
jq 
HLA-A2-FITC 
Figure  8.  Early kinetics of differentiation of CD34 + fetal liver cells in 
FTOC. CD34 + , lineage-negative, fetal liver cells from a donor of 19 wk 
gestational age, were obtained as described in Materials and Methods. The 
cells were 99.5% pure upon reanalysis. Analysis of lymphoid cells, devel- 
oped in FTOC, was done as indicated  in Materials and Methods. 
A2 + population  increased during  the culture period from 
undetectable  on  day  10  to  8%  on  day 20.  The  findings 
presented in Fig.  8 indicate that  the thymic fragments can 
support differentiation of T cells, although the period of 20 
d seems too short to observe complete T  cell development. 
As expected from our phenotypic analysis, acquisition of CD4 
and CD8 does not occur simultaneously. At days 14 to 17, 
CD4 is expressed on many more small lymphoid cells than 
CDS. Therefore at days 14 and 17, a considerable proportion 
of the cells are CD3-CD4+CD8 - . In a second experiment, 
we analyzed expression of CD1,  CD3,  CD4,  and CD8 in 
an organ culture after incubation for a period of 15-26 d after 
injection  of CD34 +  fetal  liver  cells.  In  Fig.  9  we  have 
plotted  the  percentage  of HLA-A2 +  cells  that  expressed 
CD1, CD3, CD4, and CD8 against the incubation time. It 
is shown that 57% of the cells express CD1 and 40% CD4 
at day 15.  The percentages of CD3  and CD8 + cells were 
low (6 and  11%, respectively) at  that  time point  (Fig.  9). 
This finding indicates that on day 15 the CD34 + fetal liver 
cells have developed to CD1 +  CD4-  and CD1 +  CD4 § cells. 
Upon continuation  of the incubation,  the number of cells 
that expressed CD3 and CD8 increased dramatically, and by 
day 26 most cells expressed CD1, CD3, CD4, and CD8. These 
results provide further proof that the fetal thymic fragments 
support T cell differentiation in vitro, since fetal liver CD34 
does not express CD3, CD4,  or CD8 at all.  Moreover, the 
results support the notion that CD1 appears before CD4 on 
the T  cell progenitors,  followed by CD8  and then  CD3. 
Clonogenic Potential of CD34 + and CD34-  TN  Thymo- 
cytes.  Previously, we and others (22, 26, 29) have reported 
that CD3-  clones can be established from TN thymocytes. 
Our studies and those of Poggi et al. (22) demonstrated that 
many of these CD3-  clones shared characteristics with NK 
cells.  However since some of the membrane CD3-  dones 
expressed CD3 in their cytoplasm (22,  26), the possibility 
that some of these clones were derived from T cell precursors, 
could not be ruled out. Therefore we performed several ex- 
periments in which we cloned purified CD34 § and CD34- 
TN thymocytes under conditions that have been used previ- 
ously by us  and by Denning  et  al.  (29)  to isolate CD3- 
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Figure  9.  Kinetics  of appearance of CD1, CD3, CD4, and CD8 on 
CD34 fetal liver cells. CD34 +, lineage-negative cells of a donor of 18 wk 
gestational  age were purified  and injected  into HLA-A2- thymic frag- 
ments. Plotted is the expression of CD1, CD3, CD4, and CD8 on small 
lymphoid HLA-A2 § cells against  the time. 
396  Human CD34 + Thymic T  Cell Precursors clones from TN thymocytes. As it is summarized in Table 
1,  CD3-  dones could only be isolated from CD34-  TN 
cells that are not capable of developing into CD3 + thymo- 
cytes in a FTOC. The CD34 + TN thymocytes that develop 
into CD3 + thymocytes in FTOC do not give rise to CD3- 
clones. In experiment 1, TN cells were cloned that included 
CD34 +  and CD34-  cells  and that were not depleted of 
CD56 + cells. With the exception of one CD3-  clone, all 
clones isolated in experiment 1, expressed  CD56 and were 
cytotoxic for  the  NK-sensitive  target  cell  K562  (percent 
5tCr-release >30% at an E/T ratio of 5:1). One CD3- done 
did not express CD56 and was not cytotoxic for K562 (5% 
51Cr-release at an E/T ratio of 5:1). CD3 § clones were iso- 
lated after doning of CD34 + cells in experiment 2, but the 
frequency of these clones (1/1,000)  and the fact that the 
CD34 +  cells  used in  this  experiment  were  <99%  pure, 
make it likely that the CD3 § clones isolated in experiment 
2 were derived from contaminating cells. This notion is sup- 
ported by the results of experiments 3, 4, and 5, which dem- 
onstrate that doning of CD34 + TN cells do not yield clones 
at all (experiments 4 and 5) or clones with an extremely low 
frequency (experiment 3).  In contrast, doning of CD34- 
cells yielded CD3-  clones, although the frequencies of those 
clones was not high (1/330 and 1/840 in experiments 4 and 
5, respectively). The 22 CD3-  clones isolated in experiment 
5 were tested for expression of CD56 and cytotoxic activity 
against K562. 13 clones did not express CD56 and did not 
kill (<15% lysis in a 51Cr-release assay) K562 in vitro. Nine 
clones expressed intermediate or high levels of CD56 and had 
various levels of cytotoxicity against K562 (20-95%  SlCr- 
release at an E/T ratio of 5:1) and can be considered to be 
NK cells. These experiments support the conclusion that the 
CD34 + cells are  not donogeneic under our in vitro con- 
ditions. 
Discussion 
Using a novel human FTOC system, we demonstrate in 
this report that CD34 + TN thymocytes are able to develop 
into CD4+CD8+CD3+  thymocytes, whereas CD34-  TN 
thymocytes lack this capacity. We have shown in a represen- 
tative experiment (out of three) that 300  CD34 + thymo- 
cytes  that were >99%  pure  upon reanalysis  develop  into 
CD3 + thymocytes in the FTOC. It is highly unlikely that 
the CD3 + cells observed in the FTOC would have been ex- 
clusively derived  from  those  CD3 +  cells  contaminating 
the injected CD34 + cells. More importantly, CD34-  cells, 
sorted from the same samples, which might have similar con- 
taminations with CD3 + cells,  did not develop  to CD3 + 
thymocytes. Further evidence  for the notion that the fetal 
thymic fragments induce T  cell differentiation in vitro is 
provided by the fact that CD34 + fetal liver cells rigorously 
depleted of any CD3, CD4, or CD8 positive cells develop 
into CDI+CD3+CD4+CD8 + cells in the FTOC. 
Differentiation of CD34 TN thymocytes into CD3 § cells 
has been investigated previously (21). These authors reported 
that both CD34 + and CD34-  TN thymocytes can develop 
into CD4-CD8-TCR-3,/~ + cells after coculture with TEC 
and IL-2. TCR-cx/fl + cells were not found in those cultures. 
In our hands (16) TN thymocytes as well as purified CD34 + 
thymocytes (data not shown) did not respond to IL-2 and 
no clear  evidence  was found for differentiation of CD34 + 
Table  1.  Cloning  of CD34 + and CD34-  TN Thymocytes 
Cloning  No. of clones  CD3 +  CD3-CD56 §  CD3-CD56- 
Expt.  Cell source  Purity  efficiency  tested  clones  clones  clones 
% 
1  TN*  99.5  1/110,  39  2  36  1 
2  CD34 §  98.7  1/1,000  16  16  0  0 
3  CD34"  99.7  1/10,000  6  2  4  ND 
4  CD34 §  99.8  0  0  -  --  - 
CD34-S  99.7  1/330  39  0  3911  ND 
(CD3-  only) 
5  CD34 *  99.8  0  0  -  -  - 
CD34 -  99.1  1/840  29  5  9  13 
* TN thymocytes were obtained after depletion of CD3, CD4, CD8 positive cells by magnetic bead and FACS  |  sorting. Those cells were not further 
purified  and contained  1.5%  CD56+  cells. 
* Cloning efficiencies were calculated based on limiting dilution. Graded  numbers,  usually  1,  10,  100,  and  1,000 cells per well, were cultured in 
wells of a 96-well  plate  with feeder cells as indicated  in Materials  and Methods.  Fractions  of negative wells were plotted against  the number of 
seeded cells.  The cells containing one clonogenic cell were determined  by the dose corresponding  to 0.37  negative cultures  as described  (28). 
s In expts.  2-5, we used purified CD34 + cells that were rigorously depleted of CD3, CD4, CDS, CD14, CD19, CD33, and CD56 positive cells, 
as indicated  in Materials  and  Methods. 
II In expt.  4,  expression  of CD56 on the CD3-  clones was  not investigated. 
397  Galy et al. thymocytes into TCR-~///i + after a short-term (up to 6 d) 
incubation in the presence of purified TEC, isolated as de- 
scribed previously (27,  28) and IL-7. A fundamental differ- 
ence with the results of Kurtzberg et al. (21) is the fact that 
in our hands, CD34-  cells did not possess the capacity to 
develop into CD3 + cells either in FTOC as shown here, or 
in coculture with TEC and cytokines (results not shown). 
A possible explanation for the differences in results of our 
group and of Kurtzberg et al. (21) may be the purity of the 
cell preparations. Kurtzberg and co-workers (14, 21) depleted 
thymocytes from CD3 + cells using complement mediated 
lysis and panning. In our hands, complement mediated lysis 
in combination with panning is inadequate to achieve a strin- 
gent purity. In addition, the possibility exists that the com- 
plement mediated lysis procedure involves incubation of TN 
cells with anti-CD3 mAbs at 37~  which may lead to rapid 
downregulation of the TCR-CD3  complex. The depleted 
cell population may therefore contain phenotypically CD3- 
cells that are in fact mature T cells with a modulated receptor. 
In addition, it is possible that,  in the absence of stringent 
fluorescent cell sorting,  the CD34-  populations may have 
been contaminated with cells that have a very low level of 
expression of CD3-TCR-3,/8 complex (15) which is upregu- 
lated by in vitro culture. In that case, it is appropriate to speak 
of maturation rather than differentiation (15). We took spe- 
cial care to diminish the possibility of isolating thymocytes 
with a low expression of CD3 or with a modulated CD3-TCR 
complex. The separation procedure was carried out at 4~ 
and crosslinking of the CD3-TCR complex during the sepa- 
ration procedure was avoided. Moreover, we used anti-CD3- 
PE, which is more sensitive than FITC-labeled anti-CD3 mAb 
and which allows for a  more stringent  sorting of CD3- 
cells. 
Having established that thymic precursors of CD3 § CD4 + 
CD8 + thymocytes express CD34,  we were able to address 
the question of how different immature thymic subpopula- 
tions, which have been described previously, relate to one an- 
other. Here and in our previous report (16) we identified five 
subsets  of CD3-  thymocytes. These populations  had dif- 
ferent levels of CD34 expression. Terstappen et al. (30) have 
shown that the appearance of lineage-specific markers on several 
hematopoietic lineages is accompanied by a decrease in CD34 
expression. For example, an increase of CD71 in the erythroid, 
CD33 in the myeloid lineage, and CD10 in the B cell lineage 
parallels a decrease in CD34 expression (30).  Moreover, the 
level of CD34 expression in the myeloid lineage correlates 
with the plating efficiency  of single cells for CFU blasts (30). 
Based on the relative expression of CD34,  the results sug- 
gest that CD1-CD34 + TN thymocytes are the most im- 
mature thymocytes, as has been proposed earlier (8), and that 
CDI+CD4+CDfcr  are the most mature CD3-  thymo- 
cytes. The proposed sequence for early thymocyte differenti- 
ation,  shown in Fig.  10, is consistent with the kinetics of 
development of CD34 + fetal liver cells in FTOC. CD4 ap- 
pears  before  CD8  as  indicated  by  the  observation  that 
CD4+CD8 -  lymphoid cells  are  present  by  days  14-19, 
whereas at later stages  almost all thymocytes express both 
CD4 and CDf. At early time points the number of CD1 + 
cells exceeded that of CD4 + cells indicating that CD1 ap- 
pears before CD4.  We have not yet been able to time the 
appearance of CD3-CD4+CD8c~+ 3-  cells in the FTOC, 
because this required a four-color analysis, which is difficult 
to perform in a reliable fashion with the limited number of 
cells that is obtained in FTOC experiments. It was found 
however, that freshly purified CD3-CD4+CD8 -  thymocytes 
respond to IL-7 and develop into CD3-CD4+CD8oe+ B- 
after culture in IL-7 (data not shown), providing additional 
support for the notion that CD3-CD4+CD8 -  are the di- 
rect precursors of CD4+CD8oe+3-  thymocytes. 
Expression of CD4 and CD8 on immature human thymo- 
cytes is similar to that on the murine thymus, although there 
are some differences.  A CD3-CD4 +  CD8-  thymic precur- 
sor population has also been described in the mouse (31, 32). 
In  addition to  these CD4 + immature cells,  CD3+CD4 - 
CD8 + immature mouse thymocytes have been found that 
express  both  CD8oe  and  3  (33).  The  frequencies  of 
CD3-CD4 + and CD3-CD8 + SP thymocytes seem to be 
strain  dependent.  A  CD3- CD4- CD8 +  intermediate cell 
population has also been observed in the rat thymus (34). 
There is evidence that SP immature thymocytes are inter- 
mediates between TN and DP thymocytes (35, 36). Whereas 
our findings  support  the notion  that  CD3-CD4+CD8 - 
cells are the precursors ofDP thymocytes, we have not found 
evidence for  the existence of a  CD3-CD4-CD8 +  inter- 
mediate population in the human thymus, that had been postu- 
lated (37). 
MODEL OF EARLY  STAGES  OF HUMAN  THYMIC  DEVELOPMENT 
CD3§ 
CD1-  CD1 §  CD1 +  CDI,~  CDI§ 
CD44, 
CD~  Cl~b  CD4+  CD4+  CD4~. 
CD8§ 
CDS-  CDS-  CDS-  CDS(~+!3-  CDSc~+l~- 
CD34+,~,.  CD34++  CD34+  CD34§  CD34- 
Figure  10. 
development. 
Model of early stages of human thymic T call 
398  Human CD34 § Thymic T Cell Precursors Recently we and others (22, 26, 29, 38) have isolated cloned 
lines of CD3-  cells that were derived from TN thymocytes. 
In our previous (26) and present  study, almost all of these 
TN clones (derived from TN thymocytes without depletion 
of CD56 + cells and further purification of CD34 + cells) ex- 
pressed CD56 and these clones mediated cytotoxic activity 
against  NK-sensitive target cells.  It was found however, in 
our  previous  study,  that  some of the  cell  surface  CD3- 
clones expressed cytoplasmic CD3/~ and E proteins that were 
considered to be exclusively expressed in T  cells,  although 
the TCR genes of those cytoplasmic CD3 + clones were in 
their germline configuration. Cytoplasmic CD3 proteins were 
also detected in thymic cell surface CD3-  clones isolated by 
Mingari and co-workers (22, 38). Denning et al. (29) reported 
isolation of CD4 + and CD8 + , SP CD3-  clones from TN 
thymocytes using the same conditions  we have used.  The 
phenotype of the CD4 + SP CD3-  clones, which we have 
also isolated from fetal TN thymocytes (Spits,  H., unpub- 
lished observations) is similar  to that of the immature CD4 + 
thymocytes, and this may have suggested that  some T  cell 
progenitors have in vitro clonogenic potential. The findings 
reported here, however, argue against the interpretation that 
CD3-  clones isolated from TN thymocytes are derived from 
T  cell precursors.  The in vitro clonogenic potential of TN 
thymocytes resides exclusively in the CD34-  TN population 
that has no capacity to differentiate into CD3 + thymocytes. 
In addition,  three attempts  to directly clone CD3-CD4 + 
CD8-CD34 +  thymocytes with  the  FACStar  Plus  |  or by 
limiting dilution failed (data not shown), indicating that the 
CD3-CD4+CD8 -  clones obtained in our studies and those 
of Denning  et  al.  (29)  are not  derived from  the  CD4  SP 
precursor population.  The finding that CD34 + TN thymo- 
cytes do not yield in vitro clonogenic cells,  does not mean 
that these cells do not contain NK cell precursors, as has been 
found in immature fetal mouse thymocytes (39). It may well 
be possible that CD34 + cells do not differentiate to NK cells 
in feeder cells plus IL-2. It was observed that  a number of 
CD3-  clones obtained from CD34 + TN cells (depleted of 
CD56 + cells) did not express CD56 and were not cytotoxic. 
This observation strongly suggests that the majority of the 
CD3-  clones obtained from the CD34-  thymocytes are de- 
rived from CD3-CD56-  cells  as we have never observed 
disappearance  of CD56 from CD56 + clones.  The CD56 + 
clones established from CD34-CD56-  thymocytes may ei- 
ther have been derived from contaminating CD56 + cells or 
may have acquired CD56 during the cloning procedure. The 
phenotype of the CD3-CD56-  clones is very similar  to that 
of CD3 - CD56-  clones we have established from fetal liver 
and  characterized  in  detail  (40).  The  exact  nature  of the 
CD3-CD56-  cells remains unclear,  but it is possible that 
these cells  are the  immediate  precursors  of CD3-CD56 + 
NK cells. Extensive characterization  of CD3-  CD56-  clones 
is presently under way (Sanchez, M.-J., H. Spits, S. Verma, 
L. Lanier, and J. H. Phillips,  manuscript in preparation). Since 
the CD3-CD56-  clones are derived from CD34-  thymo- 
cytes that do not have the capacity to differentiate to T cells, 
it is unlikely that  these CD3-CD56-  clones are represen- 
tative  of  precursors  of  CD3+CD4+CD8 +  thymocytes. 
Taken together, we believe that cell surface CD3-  clones de- 
rived from TN thymocytes, even those that express cytoplasmic 
CD3, CD4, or CD8, are more related to NK than to T cells. 
Expression of CD8 on NK cells is well-established. Expres- 
sion of cytoplasmic CD3 is not exclusively confined to the 
T  cell lineage but these proteins  are also expressed in  the 
majority of fetal NK cells (41). 
The demonstration that all committed TN thymic T cell 
precursors express CD34, will allow for a better assessment 
of the purity of T cell progenitors after purification and will 
lead to a better characterization of these ceils. Moreover, the 
finding that both CD34 + fetal liver ceils and CD34 + T cell 
progenitors from thymus develop into T  cells in a FTOC, 
will allow dissection of prethymic stages ofT cell development. 
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